Skandinaviska Enskilda Banken (SEB)’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-99,400
| Closed | -$312K | – | 955 |
|
|
2019
Q2 | $312K | Sell |
99,400
-610,400
| -86% | -$1.92M | ﹤0.01% | 757 |
|
|
2019
Q1 | $2.64M | Sell |
709,800
-59,600
| -8% | -$222K | 0.02% | 403 |
|
|
2018
Q4 | $2.23M | Sell |
769,400
-392,400
| -34% | -$1.14M | 0.02% | 445 |
|
|
2018
Q3 | $3.06M | Buy |
1,161,800
+240,100
| +26% | +$632K | 0.02% | 394 |
|
|
2018
Q2 | $2.16M | Buy |
921,700
+105,500
| +13% | +$247K | 0.02% | 416 |
|
|
2018
Q1 | $2.4M | Sell |
816,200
-41,800
| -5% | -$123K | 0.02% | 355 |
|
|
2017
Q4 | $2.35M | Sell |
858,000
-401,300
| -32% | -$1.1M | 0.02% | 407 |
|
|
2017
Q3 | $4.27M | Buy |
1,259,300
+88,400
| +8% | +$300K | 0.04% | 320 |
|
|
2017
Q2 | $2.89M | Sell |
1,170,900
-431,700
| -27% | -$1.07M | 0.03% | 392 |
|
|
2017
Q1 | $3.64M | Sell |
1,602,600
-94,400
| -6% | -$214K | 0.04% | 336 |
|
|
2016
Q4 | $3.6M | Buy |
1,697,000
+177,600
| +12% | +$377K | 0.04% | 287 |
|
|
2016
Q3 | $5.09M | Buy |
1,519,400
+156,000
| +11% | +$523K | 0.06% | 256 |
|
|
2016
Q2 | $4.28M | Buy |
1,363,400
+140,900
| +12% | +$442K | 0.05% | 278 |
|
|
2016
Q1 | $4.07M | Sell |
1,222,500
-331,900
| -21% | -$1.11M | 0.05% | 284 |
|
|
2015
Q4 | $5.5M | Buy |
+1,554,400
| New | +$5.5M | 0.07% | 201 |
|